Document is current
Any future updates will be listed below
-
Authors
Gupta, Santosh https://orcid.org/0000-0003-1733-7382
Sharma, Akriti
Rajakannu, Muthukumarassamy
Bisevac, Jovana
Rela, Mohamed
Verma, Rama Shanker
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Accepted: 4 August 2024
First Online: 11 September 2024
Declarations
:
: The patient(s) or their guardian(s)/legally authorized representative(s) provided written informed consent for participation in the study and/or the use of samples. Information regarding ethical approval as follows. Animal study: Title—“Development of vascularized liver tissue using Mesenchymal Stem Cells (MSCs) and HUVECs in decellularized liver biomatrix”, Approval no—IEC/2018/01/RSV-6/10 approved date – 15.07.2018. Human sample: Title – “Reengineering vascularized liver tissue using decellularized liver matrix”. Approval no – 03092018, Approval date – 04.09.2018. No clinical data from healthy or surviving liver ailment related patients were used in the study.
: The study does not include person data in any form. Cadaveric liver organ was used in the present study and the ethical information approved by the institute has been included under the section “” in the materials and method section. The patient(s) or their guardian(s)/legally authorized representative(s) provided written informed consent for participation in the study and/or the use of samples.
: The authors declare no conflicts of interest.
